Toadflax

Toadflax (Linaria vulgaris Mill.): A Comprehensive Reference

1. Identity and Botanical Description

Nomenclature and Taxonomy

Linaria vulgaris, the common toadflax, is a species of flowering plant in the family Plantaginaceae, native to Europe and northern, central, and eastern Asia. It is widely known by several vernacular names: yellow toadflax, also called "butter and eggs" or "wild snapdragon," is one of about 130 species of Linaria native to Eurasia. Additional historical common names include "snap-dragon," "ramsted," eggs and butter, eggs and bacon, eggs and collops, bread and butter, and buttered haycocks, all referring to the plant's characteristic yellow and orange bicoloured flowers.

Older botanical literature and early pharmacopoeias frequently list the species under its synonym Antirrhinum linaria L., and also as Antirrhinum linaria L., Antirrhinum linarioides L., and Antirrhinum vulgaris L. Traditionally placed in the figwort family (Scrophulariaceae), taxonomists have since reclassified Linaria as part of the Plantain family (Plantaginaceae) based on genetic evidence.

Three subspecies are accepted by the Plants of the World Online database: Linaria vulgaris subsp. vulgaris (Europe, northern Asia); Linaria vulgaris subsp. chinensis (Bunge ex Debeaux) D.Y.Hong (eastern Asia: China, Korea); and Linaria vulgaris subsp. pinetorum Kosachev (Altai Mountains of central Asia). The closely related Linaria acutiloba Fisch. from central and northeastern Asia is treated by the Flora of China as an additional subspecies.

The scientific name Linaria means "resembling linum" (flax), which the foliage of some species superficially resembles. The genus name comes from the Latin noun linus, meaning flax or linen. The specific epithet vulgaris means "common."

Morphological Description

It is a perennial plant with short spreading roots, erect to decumbent stems 15–90 cm (6–35 in) high, with fine, threadlike, glaucous blue-green leaves 2–8 cm long and 1–5 mm broad. Its leaves are lanceolate, arranged alternately, and the flowers bloom in dense racemes of golden yellow petals with an orange throat. The flower morphology is characteristically personate (two-lipped, snapdragon-like) with a prominent spur at the base of the corolla.

Geographic Range and Habitat

It has also been introduced to North America and is now common there. Yellow toadflax is an escaped ornamental brought to North America in the mid-1800s. A summer plant that copes better than most with dry spells and blooms from mid-June until late October or even into November, common toadflax favours disturbed wasteland and the edges of paths through dry grassland; it is also seen in hedgerows and on well-drained grassy banks. This perennial plant occurs throughout most of temperate North America and is listed as a noxious weed in several western U.S. states and Canadian provinces. Because it contains a poisonous glucoside that may be mildly toxic to livestock, it is a particular problem in rangeland, although it is also unpalatable, so reports of livestock poisoning are rare.

Closely Related Species

There are up to 100 other species of Linaria, but the most common one with which L. vulgaris could be confused is L. dalmatica (Dalmatian toadflax), also known as L. genistifolia. The genus is native to temperate regions of Europe, northern Africa, and Asia, with the highest species diversity in the Mediterranean region.

Commercial and Prepared Forms

The most commonly used raw material is the herb of common toadflax (Herba Linariae), which consists of dried aerial parts of the plant collected during flowering. For medicinal purposes, infusions, decoctions, tinctures, extracts, as well as ointments and compresses for external use are prepared from it. L. vulgaris continues to be sold in nurseries and seed catalogues and could be imported as an ornamental or for medicinal purposes.

2. Historical and Traditional Use

Pre-Modern and Classical Antiquity

In the 1st century CE, Pedanius Dioscorides mentioned a "toad herb" used as a mild purgative and skin remedy in his De Materia Medica. Despite its reputation as a weed, this plant has been used in folk medicine for a variety of ailments. A tea made from the leaves was taken as a laxative and strong diuretic as well as for jaundice, dropsy, and enteritis with drowsiness. For skin diseases and piles, either a leaf tea or an ointment was used.

Medieval European Use

The "toad" in toadflax may relate to the plants having historically been used to treat bubonic plague, a false link having been drawn between the words "bubo" and "Bufo." It was also used in the Middle Ages for laundry starch. The 17th-century botanist William Coles suggested that the plant was so-called because toads were known to take shelter amongst its growth.

Folk and Eclectic Medical Traditions

Linaria vulgaris has a long history of use in herbal remedies for a wide variety of ailments including jaundice, dropsy, and enteritis. A laxative tea used to be made from the leaves. The leaves were also used to make ointments for various skin diseases and for treating piles.

L. vulgaris has a long history of herbal use. It acts mainly on the liver and was once widely employed as a diuretic in the treatment of oedema. It is little used now. The whole plant is described as antiphlogistic, astringent, cathartic, detergent, depurative, diuretic, hepatic, ophthalmic, and purgative. It is gathered when just coming into flower and can be used fresh or dried.

In 19th-century North American eclectic medicine, toadflax was formally described in the King's American Dispensatory (1898). The plant was recommended for "bad blood," splenic and hepatic hypertrophies, jaundice, skin diseases, and scrofula. An ointment prepared by covering 1 part of the bruised fresh plant with 10 parts of hot lard or mutton tallow forms a soothing application for hemorrhoids and similar conditions.

Butter-and-eggs toadflax was imported from Wales to Delaware by the Quakers, who cultivated it as a garden flower and medicinal herb. It was used as a yellow dye for centuries in Germany, so immigrants, especially the Mennonites, cultivated it for use in dyeing.

Folk Use as Insecticide

L. vulgaris is used in folk medicine and in homeopathy. Historically, it has been used as an insecticide, for example in animal bedding, as a yellow dye, and as a plant of religious and magical attributes.

Veterinary Use

The plant may be mildly toxic to livestock, but has also been used to treat cattle with rumination problems.

Decline from Formal Pharmacopoeias

Over time, perceptions shifted. In the 19th century, botanical gardens labelled it a troublesome weed rather than a valued herb, and formal pharmacopoeias dropped it in favour of more potent species.

3. Key Constituents and Active Compounds

Overview of Phytochemistry

Linaria species are rich in alkaloids, iridoids, terpenes, phenolic acids, and flavonoids. A comprehensive review of the genus noted that approximately 191 distinct metabolites, including iridoids, flavonoids, and alkaloids, have been isolated from various Linaria species. The phytochemical classes include alkaloids; polyphenols including flavonoids — the latter being quite diffused and mostly present as flavones, flavonols, and their glycosides — and terpenoids including iridoids and steroids.

Flavonoids

One of the main subjects of research on common toadflax is the presence of flavonoids, such as linarin, pectolinarin, apigenin, and luteolin. These substances exhibit strong antioxidant activity, meaning that they protect cells from oxidative stress and damage by free radicals.

The principal flavonoid of L. vulgaris is linarin (also known as acacetin 7-O-rutinoside). Linarin is a flavonoid glycoside found in the Asteraceae, Lamiaceae, and Scrophulariaceae families, with diverse therapeutic benefits in laboratory studies. The main active agents identified include the flavone glycosides linarin and pectolinarin, pectin, phytosterol, tannic acid, and vitamin C.

Flavonoids linarin, apigenin, and luteolin are characterised as potent antioxidants, believed to scavenge free radicals and support vascular integrity.

Iridoid Glycosides

Iridoids constitute a chemotaxonomically significant class in toadflax. Phytochemical analysis of the extracts of Linaria vulgaris has confirmed an iridoidic pattern similar to that of other Linaria plants, with the presence of antirrinoside, antirride, 6-beta-idrossiantirride, 10-beta-glucosilaucubina, and a new iridoidic compound whose structure was demonstrated to be that of 4-carboxy-boonein.

The plant contains several compounds including glucosides and the cyanogenic glucoside prunasin. It also contains the glucoside antirrinoside.

Iridoid glycosides antirrinoside, aucubin, and catalpol are linked to mild diuretic and anti-inflammatory effects by modulating prostaglandins.

Alkaloids

Previous phytochemical investigations of L. vulgaris have revealed alkaloids, flavonoids, triterpenoids, steroids, and iridoid glucosides. The alkaloid peganine (vasicine) has been identified in the plant. Peganine exerts a cardiac-depressant effect and uterine-stimulant activity. A novel pyrroloquinazoline alkaloid was also isolated from L. vulgaris, alongside known compounds including 7-hydroxy vasicine. A new alkaloid, 1,2,3,9-tetrahydropyrrolo(2,1-b)quinazolin-1-carboxylic acid, together with eight known compounds, including 7-hydroxy vasicine and several benzyl alcohol glycosides, were isolated from the plants of Linaria vulgaris.

Phenolic Acids

Caffeic and chlorogenic acids contribute to antimicrobial activity, particularly against skin pathogens.

Linarin: Key Constituent Pharmacology

Various pharmacological studies have demonstrated linarin's diverse pharmacological activities, including analgesic, antipyretic, anti-inflammatory, and hepatoprotective activities, acetylcholinesterase and aldose reductase inhibitory activities, and sedative and neuroprotective effects.

Studies have revealed that linarin provides benefits against inflammation and various diseases, including osteoporosis, osteoarthritis, liver injuries, diabetes, hypertension, and neurodegenerative conditions such as Alzheimer's, ischemia-reperfusion, convulsions, and depression. These findings, however, derive almost entirely from in vitro and animal studies; human clinical evidence is absent.

4. Scientific Evidence by Area of Use

General Note on Evidence Strength

Toadflax is not a mainstream clinical herb. The research is promising but limited, and most of the stronger claims remain preclinical rather than proven in human trials. The medicinal profile of Linaria vulgaris is broad, but it is not fully proven. The key difference between a phytochemical profile and a clinical indication is evidence in people. Toadflax has the former much more clearly than the latter. This is why it should be described as a promising herb rather than an established therapy.

Anti-inflammatory Activity

Biological investigation of Linaria plant extracts and pure natural products has reported anti-inflammatory and analgesic activities. Research using a closely related species demonstrated this more concretely: subjection of a butanol extract of Linaria tingitana to anti-inflammatory activity testing showed that it exhibited a concentration-dependent stabilisation of HRBC membrane, inhibition of protein denaturation, and nitric oxide scavenging effect in vitro. These results were confirmed in vivo, where the extract was found most pronounced at 200 mg/kg after carrageenan injection, significantly reducing swelling in both early and late phases of carrageenan-evoked oedema, as well as a significant reduction in the accumulation of infiltrating cells, inhibition of myeloperoxidase activity, and suppressed lipid peroxidation. This study was conducted in rodents; no equivalent human data exist for toadflax extracts.

For linarin specifically, in vitro and cell-based research has been informative. The flavonoid glycoside linarin has an anti-inflammatory effect, in part through the suppression of phagocytosis, cytokine production, and antigen presentation in macrophages. These findings are from cell-culture models and do not constitute clinical evidence.

Pulmonary and Respiratory Research (Linarin)

An animal study (2025) explored linarin's potential in asthma. Investigators assessed the ability of the bioactive flavone linarin (LIN) to prevent asthma in an ovalbumin (OVA)-induced rat model. Experimental rats' body weight and relative lung weight were measured after each treatment. Indices of oxidative stress in lung tissue and erythrocytes were assessed, and analyses were conducted on hematological assays, measurement of histamine release in BALF fluid, and inflammatory markers found in blood and BALF including IL-4. The study investigated the anti-inflammatory and antioxidant characteristics of linarin for the treatment of asthma. This research is preclinical (animal model only) and cannot be extrapolated directly to human therapeutic use.

A separate published study investigated linarin in a model of acute lung injury: linarin may be a potential treatment for acute lung injury (ALI) as it reportedly has antioxidant, anti-inflammatory, and apoptotic-regulating activity. Saline and LR (12.5, 25, and 50 mg/kg) were applied to male C57BL/6 mice via gavage, followed by intratracheal injection with lipopolysaccharide (LPS). LR pretreatment attenuated LPS-induced ALI and platelet activation and reduced CD41 expression levels and neutrophil platelet aggregates. Additionally, LPS-triggered pulmonary myeloperoxidase activity and neutrophil infiltration in lung tissues was eliminated by LR dose-dependently. Again, this is rodent preclinical research only.

Hepatoprotective Activity (Linarin)

Linarin's mechanism in liver protection has been investigated in mouse models. Linarin administration decreased liver cell death and reduced pro-inflammatory cytokines and oxidative stress. Mechanistically, increased activation of Nrf2 signalling resulted in antioxidative effects and mitochondrial protection. Inhibition of TLR4/MyD88 and MAPK signalling was associated with anti-inflammatory activity. The study used carbon tetrachloride (CCl₄)-induced acute liver injury in mice, not human subjects.

Antioxidant Activity

Linaria extracts exhibit antiproliferative, cytotoxic, antibacterial, anti-inflammatory, antioxidant, and diuretic effects, as evidenced by numerous studies highlighting these properties. These are primarily in vitro findings. The flavonoid constituents — linarin, apigenin, and luteolin — are well-characterised antioxidants in general pharmacological literature, with mechanisms including free-radical scavenging, enzyme inhibition, and modulation of redox-sensitive signalling pathways. Flavonoids exhibit powerful antioxidative, anti-inflammatory, antimutagenic, antimicrobial, anticarcinogenic, and vascular actions. Several enzymes including aldose reductase, Ca²⁺ ATPase, xanthine oxidase (XO), cyclooxygenases (COXs), lipoxygenase, and phosphoinositide 3-kinase are potently inhibited by them.

Acetylcholinesterase Inhibition and Neuroprotection (Linarin)

Biological assessments of linarin have exhibited promising activities, particularly the remedial effects on central nervous system (CNS) disorders, with remarkable sleep-enhancing and sedative effects, as well as acetylcholinesterase (AChE) inhibitory activity highlighted. Linarin has also indicated promising anti-osteoblast proliferation and differentiation effects, suggesting a bone-formation effect. Further pharmacological assessments of LN and its optimised semi-synthetic derivatives, specifically its therapeutic characteristics on osteoarthritis and osteoporosis, might lead to uncovering potential drug candidates. All of this evidence remains in vitro or animal-level; no human clinical trials have been conducted.

Diuretic and Hepatic Activity

The traditional use of toadflax as a diuretic and liver herb has the longest historical record but the weakest modern scientific evidence in humans. Yellow toadflax has a long history of herbal use. It acts mainly on the liver and was once widely employed as a diuretic in the treatment of oedema. It is little used now, but undoubtedly merits investigation. No controlled human trials on toadflax as a diuretic have been identified in the published literature.

Antitumour Potential

Results from biological investigation on plant extracts and pure natural products isolated from Linaria species have reported antitumour activity. Linaria extracts exhibit antiproliferative and cytotoxic effects. These are in vitro findings only. No human trials on toadflax for any oncological indication have been reported.

5. Body Systems and Health Areas of Association

• Hepatobiliary system: It is employed internally in the treatment of oedema, jaundice, liver diseases, and gall bladder complaints.
• Urinary system: Old herbal sources describe it as a mild diuretic, laxative, hepatic herb, and external remedy for irritated skin, poorly healing areas, and hemorrhoids.
• Gastrointestinal system: Linaria vulgaris has a long history of use in herbal remedies for a wide variety of ailments including jaundice, dropsy, and enteritis. A laxative tea used to be made from the leaves of common toadflax.
• Integumentary system (topical): Externally it is applied to haemorrhoids, skin eruptions, sores, and malignant ulcers.
• Respiratory system: The plant is used in traditional folk medicine for the treatment of coughs and asthma and as an expectorant.
• Central nervous system: Linarin specifically has been investigated for CNS effects including sleep-enhancing and sedative properties, as well as acetylcholinesterase inhibitory activity.
• Musculoskeletal system: Studies have explored linarin's potential benefits in osteoporosis and osteoarthritis.

6. Dosage Forms and Reported Dosages

No official standardised dosage monograph (e.g., Commission E, ESCOP, or WHO monograph) has been identified for Linaria vulgaris in the sources searched. The following dosage information is drawn from historical dispensatories and traditional practice references, not from clinical trials.

Dried Herb Infusion (Tea)

In traditional phytotherapy, an infusion of toadflax is prepared by pouring one tablespoon of dried herb with a glass of boiling water, then steeping for about 15–20 minutes. The plant is gathered when just coming into flower and can be used fresh or dried.

Tincture

According to the King's American Dispensatory (1898): a strong tincture (℥viii to alcohol 98 per cent Oj) may be given in doses of a fraction of a drop to 10 drops.

Decoction

Also from the King's American Dispensatory: a decoction is prepared from 1 ounce of the plant to 1 pint of water.

Topical Ointment

A cooling ointment is made by chopping the whole herb and boiling it in lard until soft, then straining. The result is a fine green ointment for piles, sores, malignant ulcers, and skin eruptions.

The dosage of Linaria vulgaris depends on the form of the preparation, the therapeutic purpose, and the individual condition of the body. Although the plant has been used for centuries in folk medicine, it contains active substances with a strong effect, so it should be handled with caution.

7. Notable Safety Considerations and Interactions

Toxicity in Livestock

The plant is regarded as toxic to livestock in Europe. Cattle generally avoid grazing stands of this plant, but there is more potential for poisoning when the animals are provided with hay with a high content of yellow toadflax. No definitive records of poisoning are found in the literature.

The plant contains several compounds including glucosides and the cyanogenic glucoside prunasin. The presence of this compound is toxicologically significant, although symptoms such as rapid breathing, cyanosis, dyspnoea, paralysis, and staggering gait are general symptoms of cyanide poisoning but have not been reported in the literature for ingestion of yellow toadflax.

Alkaloid-Related Concerns

Although Hedera helix and Linaria vulgaris are considered toxic plants, their extracts containing many bioactive compounds are commonly used in the pharmaceutical and cosmetics industries. The alkaloid peganine (vasicine), present in the genus, is pharmacologically active: peganine exerts a cardiac-depressant effect and uterine-stimulant activity. The uterine-stimulating property of peganine is consistent with traditional cautions against use during pregnancy: the plant should preferably only be prescribed by a qualified practitioner and should not be given to pregnant women.

Dose-Dependency of Adverse Effects

The plant contains active substances with a strong effect, so it should be handled with caution. Both excessive consumption and prolonged use can lead to side effects, especially affecting the digestive and urinary systems. Historical dispensatories likewise noted caution: the plant has powerful qualities as a purgative, diuretic, and for enteritis, gall bladder complaints, and oedema; dosage is critical.

No Known Clinical Drug Interaction Data

No peer-reviewed clinical pharmacokinetic or drug interaction studies specific to Linaria vulgaris preparations were identified in the sources reviewed. Given the presence of flavonoids (potential inhibitors of cytochrome P450 enzymes and P-glycoprotein in high doses) and an alkaloid with cardiac activity, theoretical interaction risks with cardiac medications, uterotonic agents, and diuretics exist but remain uncharacterised in clinical literature.

8. Scientific Significance Beyond Pharmacology: The Peloria Epimutation

Linaria vulgaris holds a special place in the history of epigenetics. The "Peloria" mutant of Linaria vulgaris, originally described by Carl von Linné in 1744, exhibits radial rather than bilateral flower symmetry. A study in 1999 found that the Peloria phenotype is caused by an epiallele of the L. vulgaris cycloidea homolog Lcyc, which showed increased levels of DNA methylation compared to wild-type. This naturally occurring mutation is not caused by a change in DNA sequence, but is a consequence of a heritable epigenetic mutation involving methylation. It is surprising that the first natural morphological mutant to be fully characterised should trace to methylation, given the rarity of this mutational mechanism in the laboratory. This indicates that epigenetic mutations may play a more significant role in evolution than had hitherto been suspected. While not directly related to dietary supplement use, this landmark biological discovery has made L. vulgaris a model organism in plant epigenetics research.

9. Evidence Summary

The body of evidence for Linaria vulgaris as a medicinal plant can be summarised as follows:

• Traditional use is well-documented across European folk medicine, 19th-century North American eclectic practice, and botanical literature, primarily for diuretic, laxative, hepatic, and topical applications.
• Phytochemical characterisation is moderately advanced: key constituents (linarin, pectolinarin, iridoids including antirrinoside, alkaloids including peganine) have been isolated and structurally confirmed.
• Preclinical pharmacology (in vitro and animal studies) supports plausibility for anti-inflammatory, antioxidant, hepatoprotective, and mild diuretic effects, primarily attributable to the flavonoid linarin and iridoid glycosides.
• Human clinical evidence is absent. No randomised controlled trials, clinical pharmacokinetic studies, or controlled human studies on Linaria vulgaris preparations as a whole have been identified. All mechanistic and pharmacological claims rest on in vitro data or rodent models.
• Historical records from Dioscorides to Appalachian folk medicine illuminate its longstanding use, while modern in vitro and animal studies hint at real physiological effects. More human trials are needed to fully endorse clinical applications.

References

• Wikipedia — Linaria vulgaris
• Wikipedia — Linaria (genus)
• CABI Compendium — Linaria vulgaris (common toadflax)
• University of Wisconsin–Madison Extension — Yellow Toadflax, Linaria vulgaris
• First Nature — Linaria vulgaris, Common Toadflax
• Fareham Borough Council — Common Toadflax (Linaria vulgaris) Factsheet
• PubMed — Chemotaxonomy of iridoids in Linaria vulgaris
• ScienceDirect — Chemical constituents and biological activities of the genus Linaria (Scrophulariaceae) [review]
• PMC — Therapeutic Promises of Bioactive Linarin, a Glycosylated Flavonoid: A Comprehensive Review With Mechanistic Insight (2024)
• PMC — Linarin, a Glycosylated Flavonoid, with Potential Therapeutic Attributes: A Comprehensive Review
• PMC — Linarin Protects Against CCl4-Induced Acute Liver Injury via Activating Autophagy and Inhibiting the Inflammatory Response: Involving the TLR4/MAPK/Nrf2 Pathway
• PMC — Linarin prevents LPS-induced acute lung injury by suppressing oxidative stress and inflammation via inhibition of TXNIP/NLRP3 and NF-κB pathways
• PMC — The Effect of Linarin on Relevant Inflammatory Markers in Ovalbumin-Induced Asthma Rat Models (2025)
• PMC — Characterization of the In Vivo and In Vitro Metabolites of Linarin in Rat Biosamples and Intestinal Flora
• PubMed — Iridoids and anti-inflammatory properties of n-butanol extract of Linaria tingitana
• Springer — Linarin down-regulates phagocytosis, pro-inflammatory cytokine production, and activation marker expression in RAW264.7 macrophages
• VitaLibrary — Toadflax: Digestive and Topical Uses, Key Ingredients, Dosage, and Risks
• Henriette's Herbal — Linaria (King's American Dispensatory, 1898)
• ePharmacognosy — Yellow Toadflax Linaria vulgaris — Poisonous Plants
• ResearchGate — A New Pyrroloquinazoline Alkaloid from Linaria vulgaris
• ScienceDirect — Increased CG, CHG and CHH methylation at the cycloidea gene in the "Peloria" mutant of Linaria vulgaris
• ResearchGate — An epigenetic mutation responsible for natural variation in floral symmetry (Cubas et al., 1999)
• ScienceDirect Topics — Linaria vulgaris overview
• Academia.edu — Chemical constituents and biological activities of the genus Linaria (Natural Product Research, 2015)
• CWMA — Dalmatian Toadflax (alkaloid and peganine toxicity)
• Herbs2000 — Common Toadflax
• Natural Medicinal Herbs — Yellow Toadflax (Linaria vulgaris)